Menthol And Zinc Oxide Ointment
NDC Package 10135-701-04
Package Information
Menthol And Zinc Oxide ointment is cleans with mild skin cleanserPat dry or allow to air dryApply a thin layer of ointment to reddened or irritated skin 2-4 times daily, or after each incontinent episode or diaper change to promote comfort and long lasting protection. This formulation utilizes a ointment delivery system. Marketed by Marlex Pharmaceuticals, Inc., this product is identified by NDC 10135-701 and is authorized under FDA application M015.
Identification & Billing
- RxCUI: 2123045 - menthol 0.44 % / zinc oxide 20.6 % Topical Ointment
- RxCUI: 2123045 - menthol 0.0044 MG/MG / zinc oxide 0.206 MG/MG Topical Ointment
- RxCUI: 2123045 - Menthol 0.0044 MG/MG / ZNO 0.206 MG/MG Topical Ointment
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 10135 - Marlex Pharmaceuticals, Inc.
- 10135-701 - Menthol And Zinc Oxide
- 10135-701-04 - 113 g in 1 TUBE
- 10135-701 - Menthol And Zinc Oxide
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 10135-701-04 identifies a specific commercial package of 113 g in 1 tube of Menthol And Zinc Oxide, a human over the counter drug labeled by Marlex Pharmaceuticals, Inc.. This product is billed per "GM" gram and contains an estimated amount of 113 billable units per package. This ointment is formulated for topical use and contains menthol; zinc oxide as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Marlex Pharmaceuticals, Inc. on May 01, 2021. The current certification is valid through December 31, 2026.
How is this Marlex Pharmaceuticals, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 10135070104. Quantities are measured in per "gm or gram", products billed per gram are products measured by weight.. There are 113 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.